Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database
Background: The relationship between the size of the primary tumor and the prognosis of patients with metastatic renal cell carcinoma (mRCC) is unclear. In this study, we aimed to investigate the significance of the size of the primary tumor in mRCC. Methods: We retrospectively reviewed the data of...
Main Authors: | Weixing Jiang MD, Jianzhong Shou MD, Hongzhe Shi MD, Li Wen MD, Huijuan Zhang MD, Shan Zheng MD, Changling Li MD, Jianhui Ma MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211019507 |
Similar Items
-
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases
by: Ulka Vaishampayan, MD, et al.
Published: (2019-10-01) -
Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01) -
Construction and Validation of Nomograms for Predicting the Prognosis of Juvenile Osteosarcoma: A Real-World Analysis in the SEER Database
by: Yao Jiang MD, et al.
Published: (2020-10-01) -
Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
by: Paul Russo, et al.
Published: (2007-01-01) -
The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database
by: Chengcheng Cao MD, et al.
Published: (2020-12-01)